- -Biogen Idec is working on a a treatment that works to reduce beta amyloid levels in the brain. As announced yesterday, Their drug BIIB037 is designed to eliminate the plaque formed by the beta amyloids. The levels were reduced in a dose- and time-dependent fashion. Find out more about this treatment showing success in the early Phases at the Wall Street Journal.
- - Dr. Eva Feldman, researcher at the University of Michigan, has been working with stem cell therapies. Fetal stem cells were injected into the brains of mice that were engineered to develop Alzheimer's. Early studies show that the mice that received the treatment did not show the cognitive degeneration that those who used the placebo did. Find out more about this trail at The Detroit News.
- -The National Institute on Aging has developed a new blood test that could prove to identify Alzheimer's Disease up to ten years before symptoms are exhibited. According to USA Today, Tests are showing 100% accuracy with all those who have tested so far. It has only been tested in 174 individuals so far, but early tests show promise. By identifying the disease earlier, it would allow for more individuals to participate in clinical trials before their disease progresses beyond help.
Later this month, we're pleased to team up with Citeline's Laura Runkel, Associate Director of CNS, Autoimmune/Inflammation & Ophthalmology, as she looks at other treatments that are in the pipeline to better identify and treat Alzheimer's disease. Register to join her web seminar on December 17. Mention priority code XP2000W3BLOG.